Older patients and patients with an increased risk of adverse reactions;
In elderly patients, patients with rheumatoid arthritis and ankylosing spondylitis treatment recommended dose for 7.5mg/days. Starting dose in patients with increased risk of adverse reactions to 7.5mg/days.
Patients with renal insufficiency:
Patients with severe renal failure and need dialysis, the dose should not exceed 7.5mg/days.
Patients with mild to moderate renal insufficiency do not need to adjust the dosage (such as patients with creatinine clearance greater than 25ml/minutes).
Patients with severe renal failure without dialysis, see [taboo].
Patients with hepatic insufficiency: In patients with mild and moderate hepatic insufficiency no need to adjust the dose. In patients with severe hepatic insufficiency, see [taboo].
Children: This product is not for use in children under 15 years of age. Meloxicam has other forms, may apply.